Gliolan 5-ALA: A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study

September 09, 2016
https://clinicaltrials.gov/ct2/show/NCT02632370
Cancer - Brain
Principal Investigator: Steven N Kalkanis, MD
Brain cancer, recurrent brain cancer, glioblastoma, brain cancer surgery, surgery